Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 278
Filtrar
Más filtros

Tipo del documento
Publication year range
1.
J Infect Dis ; 229(6): 1679-1687, 2024 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-38214565

RESUMEN

BACKGROUND: Escherichia coli is frequently responsible for bloodstream infections (BSIs). Among digestive BSIs, biliary infections appear to be less severe. Respective roles of host factors, bacterial determinants (phylogroups, virulence, and antibiotic resistance), and portal of entry on outcome are unknown. METHODS: Clinical characteristics and prognosis of 770 episodes of E coli BSI were analyzed and isolates sequenced (Illumina technology) comparing phylogroups, multilocus sequence type, virulence, and resistance gene content. BSI isolates were compared with 362 commensal E coli from healthy subjects. RESULTS: Among 770 episodes, 135 were biliary, 156 nonbiliary digestive, and 479 urinary. Compared to urinary infections, BSIs of digestive origin occurred significantly more in men, comorbid, and immunocompromised patients. Digestive portal of entry was significantly associated with septic shock and death. Among digestive infections, patients with biliary infections were less likely to die (P = .032), despite comparable initial severity. Biliary E coli resembled commensals (phylogroup distribution, sequence type, and few virulence-associated genes) whereas nonbiliary digestive and urinary strains carried many virulence-associated genes. CONCLUSIONS: Escherichia coli strains responsible for biliary infections exhibit commensal characteristics and are associated with lower mortality rates, despite similar initial severity, than other digestive BSIs. Biliary drainage in addition to antibiotics in the management of biliary infections may explain improved outcome.


Asunto(s)
Bacteriemia , Infecciones por Escherichia coli , Escherichia coli , Humanos , Escherichia coli/genética , Escherichia coli/aislamiento & purificación , Escherichia coli/patogenicidad , Masculino , Infecciones por Escherichia coli/microbiología , Femenino , Persona de Mediana Edad , Bacteriemia/microbiología , Anciano , Adulto , Factores de Virulencia/genética , Antibacterianos/uso terapéutico , Antibacterianos/farmacología , Virulencia/genética , Anciano de 80 o más Años , Tipificación de Secuencias Multilocus , Infecciones Urinarias/microbiología , Enfermedades de las Vías Biliares/microbiología , Filogenia , Farmacorresistencia Bacteriana/genética
2.
BMC Infect Dis ; 24(1): 1010, 2024 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-39300331

RESUMEN

PURPOSE: The prevalence of biliary tract diseases, which are common gastrointestinal disorders, is steadily rising. If it progresses to sepsis or septic shock, it can endanger the patient's life. Therefore, it is crucial to promptly diagnose bacterial infection in individuals suffering from biliary diseases and comprehend the risk factors associated with infection. The objective of this study was to examine the types of bacteria present in the bile of patients with biliary tract diseases, assess any alterations in their susceptibility to antimicrobial agents, and identify the risk factors contributing to the development of infection in these patients. PATIENTS AND METHODS: From June 2019 to November 2022, 317 patients of biliary tract diseases with positive bile culture were included in this hospital-based descriptive analysis. The hospital's computerized medical records were used to collect data on demographic information (including gender, age, and occupation), laboratory, and clinical findings, physical examination results, comorbidities, basic diseases, treatment history, complications, and in-hospital outcomes. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) principles. RESULTS: Of the 317 patients with positive biliary tract diseases, 247 had benign diseases and 70 had malignant diseases. Patients with benign disease experienced a higher prevalence of statistically significant symptoms such as abdominal pain (81.4% vs. 57.1%, P = 0.000), nausea (31.2% vs. 14.3%, P = 0.005), vomiting (30.0% vs. 12.9%, P = 0.004), and chills (10.9% vs. 2.9%, P = 0.039), while jaundice (12.6% vs. 37.1%, P = 0.000) was more common in patients with malignant disease. At the species level, Escherichia coli (105; 40.5%), Klebsiella pneumoniae (41; 15.8%), and Pseudomonas aeruginosa (30; 11.6%) were the most commonly found Gram-negative bacterial strains in biliary tract infection. Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were most susceptible to tigecycline, ertapenem and ceftazidime/avibactam, respectively. CONCLUSION: Gram-negative bacteria are the most commonly isolated biliary bacteria. Clinical doctors should pay attention to patients with malignant diseases with low hemoglobin, high total bilirubin and high alkaline phosphatase. Carbapenems, tigecycline, and minocycline are the recommended antibiotics for Enterobacteriaceae. In recent years, the proportion of enterococcus has gradually increased, and clinical attention should be paid to enterococcus infection. Linezolid and vancomycin were recommended for the treatment of Enterococci infections. Overall, this work can provide reference for clinical diagnosis, treatment and effective interventions.


Asunto(s)
Antibacterianos , Bilis , Enfermedades de las Vías Biliares , Centros de Atención Terciaria , Humanos , Masculino , Femenino , Enfermedades de las Vías Biliares/microbiología , Enfermedades de las Vías Biliares/epidemiología , Centros de Atención Terciaria/estadística & datos numéricos , Persona de Mediana Edad , Anciano , Adulto , Bilis/microbiología , Antibacterianos/uso terapéutico , Factores de Riesgo , Anciano de 80 o más Años , Bacterias/aislamiento & purificación , Bacterias/clasificación , Bacterias/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Infecciones Bacterianas/epidemiología , Infecciones Bacterianas/microbiología , Infecciones Bacterianas/tratamiento farmacológico , Prevalencia , Adulto Joven
3.
BMC Microbiol ; 21(1): 269, 2021 10 05.
Artículo en Inglés | MEDLINE | ID: mdl-34610799

RESUMEN

BACKGROUND: Infection in patients with acute pancreatitis, especially severe acute pancreatitis patients, is a common and important phenomenon, and the distributions and drug resistance profiles of bacteria causing biliary infection and related risk factors are dynamic. We conducted this study to explore the characteristics of and risk factors for bacterial infection in the biliary tract to understand antimicrobial susceptibility, promote the rational use of antibiotics, control multidrug-resistant bacterial infections and provide guidance for the treatment of acute pancreatitis caused by drug-resistant bacteria. METHODS: The distribution of 132 strains of biliary pathogenic bacteria in patients with acute pancreatitis from January 2016 to December 2020 were analyzed. We assessed drug resistance in the dominant Gram-negative bacteria and studied the drug resistance profiles of multidrug-resistant bacteria by classifying Enterobacteriaceae and nonfermentative bacteria. We then retrospectively analyzed the clinical data and risk factors associated with 72 strains of Gram-negative bacilli, which were divided into multidrug-resistant bacteria (50 cases) and non-multidrug-resistant bacteria (22 cases). RESULTS: The main bacteria were Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa. Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli had a 66.67% detection rate. Acinetobacter baumannii had more than 50.00% drug resistance to carbapenems, ESBL-producing Klebsiella pneumoniae had 100.00% drug resistance, and Pseudomonas aeruginosa had 66.67% resistance to carbapenems. Multivariate logistic regression analysis suggested that the administration of third- or fourth-generation cephalosporins was an independent risk factor for Gram-negative multidrug-resistant biliary bacterial infection in acute pancreatitis patients. CONCLUSION: Drug resistance among biliary pathogens in acute pancreatitis patients remains high; therefore, rational antimicrobial drug use and control measures should be carried out considering associated risk factors to improve diagnosis and treatment quality in acute pancreatitis patients.


Asunto(s)
Infecciones Bacterianas/complicaciones , Infecciones Bacterianas/epidemiología , Enfermedades de las Vías Biliares/complicaciones , Enfermedades de las Vías Biliares/microbiología , Pancreatitis/complicaciones , Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Infecciones Bacterianas/microbiología , Farmacorresistencia Bacteriana , Humanos , Pancreatitis/epidemiología , Pancreatitis/microbiología , Factores de Riesgo
4.
Dig Dis Sci ; 65(7): 2079-2088, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-31691173

RESUMEN

BACKGROUND: Secondary infection is an important factor affecting mortality and quality of life in patients with severe acute pancreatitis. The characteristics of secondary infection, which are well known to clinicians, need to be re-examined in detail, and their understanding among clinicians needs to be updated accordingly. AIM: This study aims to investigate the characteristics and drug resistance of pathogens causing severe acute pancreatitis (SAP) secondary infection, to objectively present infection situation, and to provide reference for improved clinical management. METHODS: A retrospective analysis was performed on 55 consecutive patients with SAP who developed secondary infection with an accurate evidence of bacterial/fungal culture from 2016 to 2018. The statistics included the spectrum and distribution of pathogens, the drug resistance of main pathogens, and associations between multiple infectious parameters and mortality. RESULTS: A total of 181 strains of pathogens were isolated from (peri)pancreas; bloodstream; and respiratory, urinary, and biliary systems in 55 patients. The strains included 98 g-negative bacteria, 58 g-positive bacteria, and 25 fungi. Bloodstream infection (36.5%) was the most frequent infectious complication, followed by (peri)pancreatic infection (32.0%). Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Stenotrophomonas maltophilia were predominant among gram-negative bacteria. Gram-positive bacterial infections were mainly caused by Enterococcus faecium and Staphylococcus spp. Fungal infections were predominantly caused by Candida spp. The drug resistance of pathogens causing SAP secondary infection was generally higher than the surveillance level. Patients in the death group were older (55 ± 13 years vs. 46 ± 14 years; p = 0.039) and had longer intensive care unit (ICU) stay (14 vs. 8; p = 0.026) than those in the survival group. A. baumannii infection (68.4% vs. 33%; p = 0.013), number of pathogens ≥ 4 (10 vs. 6; p = 0.005), pancreatic infection (14 vs. 15, p = 0.024), and urinary infection (8 vs. 5; p = 0.019) were significantly associated with mortality. CONCLUSION: Gram-negative bacteria are the main pathogens causing SAP secondary infection, in which nosocomial infections play a major role. The drug resistance profile of gram-negative bacteria is seriously threatening, and the commonly used antibiotics in SAP are gradually losing their effectiveness. Much attention should be paid to the rational use of antibiotics, and strategies should be established for infection prevention in SAP.


Asunto(s)
Candidiasis/microbiología , Infección Hospitalaria/microbiología , Farmacorresistencia Microbiana , Infecciones por Bacterias Gramnegativas/microbiología , Infecciones por Bacterias Grampositivas/microbiología , Pancreatitis/terapia , Acinetobacter baumannii , Adulto , Anciano , Bacteriemia/complicaciones , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Bacteriemia/mortalidad , Enfermedades de las Vías Biliares/complicaciones , Enfermedades de las Vías Biliares/tratamiento farmacológico , Enfermedades de las Vías Biliares/microbiología , Enfermedades de las Vías Biliares/mortalidad , Candida , Candidemia/complicaciones , Candidemia/tratamiento farmacológico , Candidemia/microbiología , Candidemia/mortalidad , Candidiasis/complicaciones , Candidiasis/tratamiento farmacológico , Candidiasis/mortalidad , Causas de Muerte , Coinfección/complicaciones , Coinfección/tratamiento farmacológico , Coinfección/microbiología , Coinfección/mortalidad , Infección Hospitalaria/complicaciones , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/mortalidad , Enterococcus faecium , Escherichia coli , Femenino , Infecciones por Bacterias Gramnegativas/complicaciones , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/mortalidad , Infecciones por Bacterias Grampositivas/complicaciones , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/mortalidad , Mortalidad Hospitalaria , Hospitales de Enseñanza , Hospitales Universitarios , Humanos , Unidades de Cuidados Intensivos , Infecciones Intraabdominales/complicaciones , Infecciones Intraabdominales/tratamiento farmacológico , Infecciones Intraabdominales/microbiología , Infecciones Intraabdominales/mortalidad , Klebsiella pneumoniae , Tiempo de Internación , Masculino , Persona de Mediana Edad , Pancreatitis/complicaciones
5.
World J Surg Oncol ; 18(1): 19, 2020 Jan 24.
Artículo en Inglés | MEDLINE | ID: mdl-31980025

RESUMEN

BACKGROUND: The aim of this study is to investigate the composition of microbiota in biliary tract cancer patients and healthy adults by metagenome analysis and evaluate its potential values as biomarkers for biliary tract cancer. METHODS: Patients who were diagnosed with biliary tract cancer or benign inflammation were enrolled in this study. The control group consisted of healthy adults who presented with no history of significant medical issues. We isolated bacteria-derived extracellular vesicles in the plasma. The microbiome composition was investigated with 16S rDNA metagenome analysis. We evaluated each microbiome to ensure suitability for the biliary tract cancer prediction model. RESULTS: A total of 155 patients were included in this study: 24 patients with diagnosed biliary tract cancers, 43 diagnosed with cholecystitis or cholangitis, and 88 healthy adults. The microbiome composition pattern of the biliary tract cancer differed from the microbiome composition pattern seen in healthy adult group in beta diversity analysis. The percent composition of microbiota was found to be different from the phylum to genus level. Differences in the composition of the Bifidobacteriaceae and Pseudomonaceae families and Corynebacteriaceae Corynebacterium, Oxalobacteraceae Ralstonia and Comamonadaceae Comamonas species may be used to develop predictive models for biliary tract cancer. CONCLUSION: Biliary tract cancer patients have altered microbiome composition, which represents a promising biomarker to differentiate malignant biliary tract disease from normal control group.


Asunto(s)
Neoplasias del Sistema Biliar/microbiología , Microbiota , Adulto , Anciano , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Enfermedades de las Vías Biliares/microbiología , Biomarcadores de Tumor , ADN Ribosómico/genética , Vesículas Extracelulares/microbiología , Humanos , Microbiota/genética , Persona de Mediana Edad , ARN Ribosómico 16S
6.
Br J Surg ; 106(5): 606-615, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30883708

RESUMEN

BACKGROUND: The benefit of taking intra-abdominal cultures during source control procedures in patients with complicated intra-abdominal infection (CIAI) is unknown. The aim of this study was to evaluate whether intra-abdominal cultures reduce the mortality rate of CIAI. METHODS: The Japanese Diagnosis Procedure Combination database was used to identify adult patients with CIAI who had undergone source control procedures on the first day of admission to hospital between April 2014 and March 2016. In-hospital mortality was compared between patients who did and those who did not have intra-abdominal cultures taken. A generalized linear mixed-effect logistic regression model and a random intercept per hospital were used to adjust for baseline confounders and institutional differences. Subgroup analyses were also performed according to disease cause, site of onset and severity of CIAI. RESULTS: Intra-abdominal cultures were taken from 16 303 of 41 495 included patients. Multivariable logistic regression analysis showed that patients with intra-abdominal cultures had a significantly lower mortality than those without (odds ratio 0·85, 95 per cent c.i. 0·77 to 0·95). Subgroup analyses revealed statistically significant differences in mortality between patients with and without cultures among those with lower intestinal perforation, biliary tract infection/perforation, healthcare-associated CIAI and high-risk community-acquired CIAI. CONCLUSIONS: Intra-abdominal cultures obtained during source control procedures may reduce in-hospital mortality, especially in patients with lower intestinal perforation, biliary tract infection/perforation, or healthcare-associated or high-risk community-acquired CIAI.


Asunto(s)
Técnicas Bacteriológicas/estadística & datos numéricos , Infecciones Intraabdominales/microbiología , Infecciones Intraabdominales/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Antiinfecciosos/uso terapéutico , Enfermedades de las Vías Biliares/complicaciones , Enfermedades de las Vías Biliares/microbiología , Femenino , Mortalidad Hospitalaria , Humanos , Perforación Intestinal/complicaciones , Perforación Intestinal/microbiología , Infecciones Intraabdominales/complicaciones , Infecciones Intraabdominales/tratamiento farmacológico , Japón , Masculino , Persona de Mediana Edad , Utilización de Procedimientos y Técnicas , Perforación Espontánea/complicaciones , Perforación Espontánea/microbiología
7.
Eur J Clin Microbiol Infect Dis ; 38(8): 1523-1532, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31119578

RESUMEN

Identifying an infection may be difficult in the ED. Neutrophilic leukocytosis is often used in the diagnosis of infection despite its lack of specificity in situations of stress. Our objective was to study the value of each parameter of the WBC count, in particular eosinopenia, to diagnose bacterial infections in the ED. We conducted a retrospective and observational study over a period of 6 months. All patients with one of the following diagnoses were eligible: pneumonia (9.9%), pyelonephritis (26.2%), prostatitis (8.4%), appendicitis (26.2%), cholecystitis (8.4%), and diverticular sigmoiditis (5%). A total of 466 infected patients were included for statistical analysis, and a control group of 466 uninfected patients was randomly selected in the same period of time. All leukocyte count parameters were significantly modified (p < 0.001) in the infected group compared with the control group. Neutrophils and total leukocytes remain the two most suitable parameters for the diagnosis of infections in the ED. Eosinopenia represented the most efficient parameter of the WBC count for the diagnosis of urinary and biliary tract infections. Deep eosinopenia presented a specificity of 94% for the diagnosis of infection. Any modification of the WBC count associated with an elevation of CRP (> 40 mg/L) or fever (> 38.5 °C) showed a high specificity for the diagnosis of infection. A careful analysis of the WBC count remains a valuable tool for the diagnosis of infection in the ED.


Asunto(s)
Infecciones Bacterianas/diagnóstico , Servicio de Urgencia en Hospital , Eosinófilos/patología , Recuento de Leucocitos , Adulto , Anciano , Anciano de 80 o más Años , Infecciones Bacterianas/inmunología , Enfermedades de las Vías Biliares/inmunología , Enfermedades de las Vías Biliares/microbiología , Proteína C-Reactiva/análisis , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Sensibilidad y Especificidad , Sepsis/diagnóstico , Sepsis/inmunología , Sepsis/microbiología , Índice de Severidad de la Enfermedad , Infecciones Urinarias/diagnóstico
8.
BMC Infect Dis ; 19(1): 488, 2019 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-31151426

RESUMEN

BACKGROUND: There are limited studies focusing on liver abscess with negative microbiological cultures. This study evaluated the clinical and prognostic differences of patients with culture-negative liver abscess (CNLA) compared to those with a positive culture (CPLA) and compared these factors between K. pneumoniae liver abscess (KLA) and E. coli liver abscess (ELA). METHODS: A retrospective study of the patients who admitted with a liver abscess at two tertiary hospitals in Korea from 2012 to 2016 was performed. RESULTS: Among a total of 402 patients with liver abscess, 61.2% had positive cultures. K. pneumoniae (n = 133) was the most common cause, followed by E. coli (n = 74). Patients with CPLA were significantly older (p = 0.02) and more frequently had cholelithiasis or biliary tract disease (p = 0.001) compared to patients with CNLA. In-hospital mortality (p = 0.63) and recurrence (p = 0.77) were no different between the two groups. The length of hospital stay was significantly longer in patients with CPLA (p = 0.03) compared with those with CNLA. Subgroup analysis for patients who received 3rd generation cephalosporins empirically showed that in-hospital mortality (p = 0.18) and recurrence (p = 0.27) were not also significantly different. Cholelithiasis, or biliary tract disease (p = 0.001), liver disease (p = 0.001), malignancy (p = 0.0001), and ESBL production (p = 0.0001) were found more frequently in patients with ELA compared with those with KLA. CONCLUSIONS: The prognosis of the CNLA patients was similar to that of the CPLA patients, although the length of hospital stay was shorter in the CNLA patients. The epidemiologic and clinical characteristics of the ELA patients are somewhat different than those of the KLA patients.


Asunto(s)
Absceso Piógeno Hepático/diagnóstico , Absceso Piógeno Hepático/microbiología , Adulto , Anciano , Enfermedades de las Vías Biliares/diagnóstico , Enfermedades de las Vías Biliares/epidemiología , Enfermedades de las Vías Biliares/microbiología , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/diagnóstico , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/microbiología , Femenino , Mortalidad Hospitalaria , Hospitalización/estadística & datos numéricos , Humanos , Infecciones por Klebsiella/diagnóstico , Infecciones por Klebsiella/epidemiología , Infecciones por Klebsiella/microbiología , Klebsiella pneumoniae/aislamiento & purificación , Absceso Piógeno Hepático/epidemiología , Masculino , Persona de Mediana Edad , Pronóstico , Recurrencia , República de Corea/epidemiología , Estudios Retrospectivos , Centros de Atención Terciaria/estadística & datos numéricos
9.
Biochim Biophys Acta Mol Basis Dis ; 1864(4 Pt B): 1367-1373, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-28844953

RESUMEN

The liver is a vital organ with distinctive anatomy, histology and heterogeneous cell populations. These characteristics are of particular importance in maintaining immune homeostasis within the liver microenvironments, notably the biliary tree. Cholangiocytes are the first line of defense of the biliary tree against foreign substances, and are equipped to participate through various immunological pathways. Indeed, cholangiocytes protect against pathogens by TLRs-related signaling; maintain tolerance by expression of IRAK-M and PPARγ; limit immune response by inducing apoptosis of leukocytes; present antigen by expressing human leukocyte antigen molecules and costimulatory molecules; recruit leukocytes to the target site by expressing cytokines and chemokines. However, breach of tolerance in the biliary tree results in various cholangiopathies, exemplified by primary biliary cholangitis, primary sclerosing cholangitis and biliary atresia. Lessons learned from immune tolerance of the biliary tree will provide the basis for the development of effective therapeutic approaches against autoimmune biliary tract diseases. This article is part of a Special Issue entitled: Cholangiocytes in Health and Disease edited by Jesus Banales, Marco Marzioni, Nicholas LaRusso and Peter Jansen.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Conductos Biliares/inmunología , Enfermedades de las Vías Biliares/inmunología , Células Epiteliales/inmunología , Tolerancia Inmunológica , Animales , Presentación de Antígeno/inmunología , Enfermedades Autoinmunes/microbiología , Enfermedades Autoinmunes/prevención & control , Conductos Biliares/citología , Conductos Biliares/metabolismo , Conductos Biliares/microbiología , Enfermedades de las Vías Biliares/microbiología , Enfermedades de las Vías Biliares/prevención & control , Células Epiteliales/metabolismo , Interacciones Huésped-Patógeno/inmunología , Humanos , Quinasas Asociadas a Receptores de Interleucina-1/inmunología , Quinasas Asociadas a Receptores de Interleucina-1/metabolismo , PPAR gamma/inmunología , PPAR gamma/metabolismo , Transducción de Señal/inmunología , Receptores Toll-Like/inmunología , Receptores Toll-Like/metabolismo
10.
Eur J Clin Microbiol Infect Dis ; 37(5): 953-958, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29484561

RESUMEN

Bile is a lipid-rich sterile solution produced in the liver that can be infected resulting in bactibilia. A higher incidence of postoperative infectious complications has been seen in patients with bactibilia. Recently, gram-negative bacteria have been linked to a tumor-associated inflammatory status. This study is a retrospective cohort study of 39 patients, who are over 80 years of age only (53.85% males and 46.15% females), hospitalized with diseases of the biliopancreatic system in one teaching hospital in Italy from January 2011 to December 2012 with a follow-up of 5 years. The most common biliary diseases after surgery were pancreatic head cancer (p < 0.0001) and gallbladder cancer (p = 0.0051), while the most common bacteria in the bile were E. coli (p = 0.0180) and Pseudomonas spp. (p < 0.0001). Uni- and multivariate linear correlation analysis revealed that patients with pancreatic head cancer had low survival times compared to patients with other diseases. Moreover, the bacterium type was a positive predictor of survival time compared to other variables. Our data confirm E. coli as a pathogen in patients with gallbladder and pancreatic cancer. Although the influence of bactibilia in developing surgical complications is limited, we consider that its composition is crucial to properly address the antibiotic treatment in biliary tract infections, especially in the elderly.


Asunto(s)
Infecciones Bacterianas/epidemiología , Infecciones Bacterianas/microbiología , Enfermedades de las Vías Biliares/epidemiología , Enfermedades de las Vías Biliares/microbiología , Pancreatitis/epidemiología , Pancreatitis/microbiología , Factores de Edad , Anciano de 80 o más Años , Infecciones Bacterianas/diagnóstico , Enfermedades de las Vías Biliares/diagnóstico , Infección Hospitalaria , Femenino , Hospitales de Enseñanza , Humanos , Italia/epidemiología , Masculino , Pancreatitis/diagnóstico , Estudios Retrospectivos
11.
BMC Infect Dis ; 18(1): 277, 2018 06 15.
Artículo en Inglés | MEDLINE | ID: mdl-29902981

RESUMEN

BACKGROUND: Antibiotics with anaerobic coverage are widely used for the treatment of biliary tract infection (BTI), even in the absence of isolated anaerobes. The current study aimed to investigate the differences in clinical outcomes in patients with community-onset bacteremic BTIs without anaerobic bacteremia, treated with vs. without anti-anaerobic coverage. METHODS: A retrospective analysis was conducted at a medical center in Taiwan from September 2014 to March 2016. Patients with community-onset bacteremic BTIs without anaerobic bacteremia and who were treated with appropriate antibiotics were analyzed. The clinical outcomes were compared between patients treated with and without anti-anaerobic coverage as definitive therapy after the blood culture reports were available. Multivariable and propensity score-adjusted analysis were used to identify the risk factors associated with treatment failure. RESULTS: Among the enrolled 87 patients, 63 and 24 patients were treated with and without anaerobic coverage, respectively. Escherichia coli (55.2%) and Klebsiella pneumoniae (23.0%) were the most common organisms isolated from the blood cultures. The rate of treatment failure (relapse and 28-day mortality) was similar between the groups with and without anaerobic coverage (20.6% vs. 16.7%, p = 0.677). Propensity score-adjusted multivariable analysis revealed that definitive therapy without anaerobic coverage was not a predisposing factor for treatment failure (OR = 0.92, 95% CI 0.18-4.67, p = 0.916). CONCLUSIONS: Definitive therapy without anaerobic coverage does not affect the outcomes of patients with community-onset bacteremic BTIs without anaerobes isolated from blood. Our results might provide a possible target for antibiotic stewardship interventions in BTIs.


Asunto(s)
Bacteriemia/diagnóstico , Enfermedades de las Vías Biliares/diagnóstico , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Bacteriemia/mortalidad , Bacterias Anaerobias/efectos de los fármacos , Bacterias Anaerobias/aislamiento & purificación , Enfermedades de las Vías Biliares/tratamiento farmacológico , Enfermedades de las Vías Biliares/microbiología , Enfermedades de las Vías Biliares/mortalidad , Cultivo de Sangre , Escherichia coli/aislamiento & purificación , Femenino , Humanos , Klebsiella pneumoniae/aislamiento & purificación , Masculino , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia , Taiwán , Insuficiencia del Tratamiento
12.
Ann Clin Microbiol Antimicrob ; 17(1): 13, 2018 Mar 23.
Artículo en Inglés | MEDLINE | ID: mdl-29571291

RESUMEN

BACKGROUND: The increasing incidence of carbapenem-resistant Enterobacteriaceae (CRE), has resulted in a difficult problem in the current clinical anti-infective treatment. We performed a retrospective analysis of prevalence and treatment for CRE infections patients. METHODS: This study was conducted in three tertiary care hospitals from January 1, 2010 to December 30, 2016. Baseline data, treatment, and outcomes were collected in patients with ventilator-associated bacterial pneumonia (VABP), bacteremia, complicated urinary tract infection (cUTI)/acute pyelonephritis (AP), hospital-acquired bacterial pneumonia (HABP), superficial wound infection (SWI), biliary tract infection (BTI), deep wound infection (DWI) and sterile body fluids infection (SBFI) due to CRE. RESULTS: One hundred twenty-four cases of CRE infection were identified: 31 VABP, 22 bacteremia, 18 cUTI/AP, 16 HABP, 16 SWI, 9 BTI, 7 DWI and 5 SBFI. The patient population had significant immunocompromised (33 of 124, 26.6%) and severe sepsis (43 of 124, 34.7%). The most common CRE pathogens were Klebsiella pneumoniae (84 of 124, 67.7%) and Enterobacter cloacae (24 of 124, 19.4%). And the production of IMP-type carbapenemase was the main antibiotic resistance mechanism. The majority of patients to take monotherapy for empiric therapy and dual therapy for direct treatment. Outcomes were universally poor (28-day mortality was 22.6%, 28 of 124) across all sites of infection. CONCLUSIONS: We identified a large number of cases of CRE infection in 7 years from different parts, most of these pathogens have been confirmed to produce IMP-type carbapenemases. The retrospective analysis of cases of such bacterial infections will help to control future infections of these pathogens. Despite the high mortality rate, we still found that the selection of quinolone antibiotics can be effective in the treatment of CRE producing IMP type enzymes.


Asunto(s)
Antibacterianos/uso terapéutico , Enterobacteriaceae Resistentes a los Carbapenémicos/patogenicidad , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/epidemiología , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/patogenicidad , Adulto , Anciano , Anciano de 80 o más Años , Bacteriemia/tratamiento farmacológico , Bacteriemia/epidemiología , Enfermedades de las Vías Biliares/tratamiento farmacológico , Enfermedades de las Vías Biliares/epidemiología , Enfermedades de las Vías Biliares/microbiología , Líquidos Corporales/microbiología , Enterobacteriaceae Resistentes a los Carbapenémicos/efectos de los fármacos , China , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/epidemiología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Enterobacter cloacae/patogenicidad , Enterobacteriaceae/aislamiento & purificación , Infecciones por Enterobacteriaceae/microbiología , Escherichia coli/efectos de los fármacos , Escherichia coli/patogenicidad , Femenino , Hospitalización , Hospitales , Humanos , Unidades de Cuidados Intensivos , Klebsiella oxytoca/efectos de los fármacos , Klebsiella oxytoca/patogenicidad , Klebsiella pneumoniae/patogenicidad , Masculino , Persona de Mediana Edad , Neumonía/tratamiento farmacológico , Neumonía/epidemiología , Neumonía Asociada al Ventilador/tratamiento farmacológico , Neumonía Asociada al Ventilador/epidemiología , Neumonía Asociada al Ventilador/microbiología , Prevalencia , Pielonefritis/tratamiento farmacológico , Pielonefritis/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Sepsis/tratamiento farmacológico , Sepsis/epidemiología , Centros de Atención Terciaria , Resultado del Tratamiento , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/epidemiología , Infección de Heridas/tratamiento farmacológico , Infección de Heridas/epidemiología , Adulto Joven
13.
J Infect Chemother ; 24(5): 330-340, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29555391

RESUMEN

The principle of empirical therapy for patients with intra-abdominal infections (IAI) should include antibiotics with activity against Enterobacteriaceae and Bacteroides fragilis group species. Coverage of Pseudomonas aeruginosa, Enterobacter cloacae, and Enterococcus faecalis is also recommended for hospital-associated IAI. A nationwide survey was conducted to investigate the antimicrobial susceptibility of pathogens isolated from postoperative IAI. All 504 isolates were collected at 26 institutions and referred to a central laboratory for susceptibility testing. Lower susceptibility rates to ciprofloxacin and cefepime were demonstrated in Escherichia coli. Among E. coli, 24.1% of strains produced extended-spectrum ß-lactamase (ESBL). Carbapenems, piperacillin/tazobactam, cephamycins/oxacephem, aminoglycosides, and tigecycline had high activity against E. coli, including ESBL-producing isolates. Among E. cloacae, low susceptibility rates to ceftazidime were demonstrated, whereas cefepime retained its activity. P. aeruginosa revealed high susceptibility rates to all antimicrobials tested except for imipenem. Among B. fragilis group species, low levels of susceptibility were observed for cefoxitin, moxifloxacin, and clindamycin, and high susceptibility rates were observed for piperacillin/tazobactam, meropenem, and metronidazole. Ampicillin, piperacillin, and glycopeptides had good activity against E. faecalis. Imipenem had the highest activity against E. faecalis among carbapenems. In conclusion, we suggested the empirical use of antimicrobials with the specific intent of covering the main organisms isolated from postoperative IAI. Piperacillin/tazobactam, meropenem, or doripenem, are appropriate in critically ill patients. Combination therapy of cefepime (aztreonam in patients with ß-lactam allergy) plus metronidazole plus glycopeptides, imipenem/cilastatin or cephamycins/oxacephem plus ciprofloxacin plus metronidazole are potential therapeutic options.


Asunto(s)
Antibacterianos/farmacología , Enfermedades de las Vías Biliares/microbiología , Enterobacteriaceae/efectos de los fármacos , Enterococcus faecalis/efectos de los fármacos , Peritonitis/microbiología , Complicaciones Posoperatorias/microbiología , Pseudomonas aeruginosa/efectos de los fármacos , Centros Médicos Académicos , Enfermedades de las Vías Biliares/tratamiento farmacológico , Farmacorresistencia Bacteriana Múltiple , Quimioterapia Combinada , Enterobacteriaceae/enzimología , Enterobacteriaceae/aislamiento & purificación , Enterococcus faecalis/enzimología , Enterococcus faecalis/aislamiento & purificación , Humanos , Japón , Pruebas de Sensibilidad Microbiana , Peritonitis/tratamiento farmacológico , Complicaciones Posoperatorias/tratamiento farmacológico , Pseudomonas aeruginosa/enzimología , Pseudomonas aeruginosa/aislamiento & purificación , beta-Lactamasas/metabolismo
14.
Microb Pathog ; 111: 262-268, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28867623

RESUMEN

Escherichia coli is the species that is most frequently isolated from bile of patients with biliary tract diseases. This study was aimed to investigate any association between resistance and virulence properties of these isolates with occurrence of the diseases. A total of 102 bile samples were obtained from patients subjected to endoscopic retrograde cholangiopancreatography for different biliary diseases. Clinical data were collected and culture of the bile samples was done on selective media. Resistance of characterized Escherichia coli isolates to deoxycholate sodium (0-7%) and nineteen antibiotics was determined and PCR using 16 pairs of primers targeting stx1, stx2, exhA, eae, bfp, agg, pcvd432, lt, st, ipaH, pic, pet, ast, set, sen, and cdtB genes was done. Our results showed a statistically significant association between E. coli colonization and existence of common bile duct and gallbladder stones (p value 0.028). Out of the 22 E. coli strains (22/102) multidrug resistance phenotype was present in 95.45%. None of the strains belonged to common E. coli pathotypes. However, bfp + EhxA-hly, bfp + astA, bfp + EhxA-hly + pic, and EhxA-hly + pic + astA, bfp, and astA genotypes were detected in these strains. bfp (7/22, 31.8%) and astA (5/22, 22.7%) were among most frequent virulence factors in these strains. Results of this study showed significant association between colonization of E. coli and choledocholithiasis. Unusual existence of virulence gene combinations in these strains and their resistance to DOC and multiple classes of antibiotics could be considered as possible causes of their persistence in this harsh microenvironment.


Asunto(s)
Bilis/microbiología , Enfermedades de las Vías Biliares/microbiología , Proteínas de Escherichia coli/genética , Escherichia coli/efectos de los fármacos , Escherichia coli/crecimiento & desarrollo , Escherichia coli/genética , Virulencia/genética , Conductos Biliares/microbiología , Coledocolitiasis/microbiología , ADN Bacteriano/genética , Ácido Desoxicólico/farmacología , Farmacorresistencia Bacteriana Múltiple/genética , Escherichia coli Enterotoxigénica/genética , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/microbiología , Vesícula Biliar/microbiología , Genes Bacterianos/genética , Genotipo , Humanos , Irán , Pruebas de Sensibilidad Microbiana , Fenotipo , Factores de Virulencia/genética
15.
Klin Lab Diagn ; 62(2): 112-5, 2017 Feb.
Artículo en Ruso | MEDLINE | ID: mdl-30615400

RESUMEN

The volatile fatty acids are metabolites of bacteria reflecting condition and disbiotic alterations of microflora of gastrointestinal tract. The study was carried out to determine qualitatively volatile fatty acids in saliva of children with dysfunction of biliary tract and healthy ones. The indices of volatile fatty acids were analyzed in 46 children aged 7-17 years and with dysfunction of biliary tract. The comparison group included 34 healthy children aged from 7 to 17 years. The gas-liquid chromatography was applied to qualitatively detect acetic, butyric, isovaleric acids (volatile fatty acids). The automatedgas chromatograph "Crystal deluxe 4000" with capillary column "HP-FFAP" and flame ionizing detector was used. The study established decreasing of anaerobic index, increasing of acetic, propionic acids and sum of volatile fatty acids in saliva of children of main group as opposed to children of comparison group. The possible role of bacterial metabolites and bacteria in pathogenesis of dysfunction of biliary tract in children. The description is made of one of possible mechanisms of increasing of volatile fatty acids in saliva under dysfunction of biliary tract. The integral indices of volatile fatty acids of saliva are the new additional criteria for diagnostic of dysfunction of biliary tract in children.


Asunto(s)
Enfermedades de las Vías Biliares/metabolismo , Sistema Biliar/metabolismo , Ácidos Grasos Volátiles/aislamiento & purificación , Saliva/química , Ácido Acético/aislamiento & purificación , Ácido Acético/metabolismo , Adolescente , Bacterias/metabolismo , Sistema Biliar/química , Sistema Biliar/microbiología , Sistema Biliar/patología , Enfermedades de las Vías Biliares/diagnóstico , Enfermedades de las Vías Biliares/microbiología , Enfermedades de las Vías Biliares/patología , Ácido Butírico/aislamiento & purificación , Ácido Butírico/metabolismo , Niño , Cromatografía de Gases , Ácidos Grasos Volátiles/metabolismo , Femenino , Hemiterpenos , Humanos , Masculino , Ácidos Pentanoicos/aislamiento & purificación , Ácidos Pentanoicos/metabolismo , Propionatos/aislamiento & purificación
16.
Liver Int ; 36(4): 480-7, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26561779

RESUMEN

Increasing evidence points to the contribution of the intestinal microbiome as a potentially key determinant in the initiation and/or progression of hepatobiliary disease. While current understanding of this dynamic is incomplete, exciting insights are continually being made and more are expected given the developments in molecular and high-throughput omics techniques. In this brief review, we provide a practical and updated synopsis of the interaction of the intestinal microbiome with the liver and its downstream impact on the initiation, progression and complications of hepatobiliary disease.


Asunto(s)
Enfermedades de las Vías Biliares/microbiología , Sistema Biliar/microbiología , Microbioma Gastrointestinal , Salud , Intestinos/microbiología , Hepatopatías/microbiología , Hígado/microbiología , Microbiota , Animales , Sistema Biliar/inmunología , Enfermedades de las Vías Biliares/inmunología , Interacciones Huésped-Patógeno , Humanos , Mediadores de Inflamación/inmunología , Hígado/inmunología , Hepatopatías/inmunología , Transducción de Señal/inmunología
17.
Eur J Clin Microbiol Infect Dis ; 35(8): 1331-9, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27193890

RESUMEN

Bacterial infection is considered a predisposing factor for disorders of the biliary tract. This study aimed to determine the diversity of bacterial communities in bile samples and their involvement in the occurrence of biliary tract diseases. A total of 102 bile samples were collected during endoscopic retrograde cholangiopancreatography (ERCP). Characterization of bacteria was done using culture and polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) methods. Antimicrobial susceptibility of the isolates was determined based on the Clinical and Laboratory Standards Institute (CLSI) guidelines and identity of the nucleotide sequences of differentiated bands from the DGGE gels was determined based on GenBank data. In total, 41.2 % (42/102) of the patients showed bacterial infection in their bile samples. This infection was detected in 21 % (4/19), 45.4 % (5/11), 53.5 % (15/28), and 54.5 % (24/44) of patients with common bile duct stone, microlithiasis, malignancy, and gallbladder stone, respectively. Escherichia coli showed a significant association with gallstones. Polymicrobial infection was detected in 48 % of the patients. While results of the culture method established coexistence of biofilm-forming bacteria (Pseudomonas aeruginosa, E. coli, Klebsiella pneumoniae, Enterococcus spp., and Acinetobacter spp.) in different combinations, the presence of Capnocytophaga spp., Lactococcus spp., Bacillus spp., Staphylococcus haemolyticus, Enterobacter or Citrobacter spp., Morganella spp., Salmonella spp., and Helicobacter pylori was also characterized in these samples by the PCR-DGGE method. Multidrug resistance phenotypes (87.5 %) and resistance to third- and fourth-generation cephalosporins and quinolones were common in these strains, which could evolve through their selection by bile components. Ability for biofilm formation seems to be a need for polymicrobial infection in this organ.


Asunto(s)
Bacterias/genética , Bilis/microbiología , Enfermedades de las Vías Biliares/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Bacterias/efectos de los fármacos , Sistema Biliar , Enfermedades de las Vías Biliares/cirugía , Colangiopancreatografia Retrógrada Endoscópica , Estudios de Cohortes , Electroforesis en Gel de Gradiente Desnaturalizante , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Adulto Joven
18.
Helicobacter ; 20(2): 98-105, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25381932

RESUMEN

BACKGROUND: The Helicobacter pylori is considered the important causative agent causing biliary diseases, but the H. pylori can be isolated from very few gallbladder specimens with diseases. We studied the formation of H. pylori L-forms in bile in vitro and isolated the H. pylori L-forms from gallbladder of patients with biliary diseases. METHODS: We inoculated the H. pylori into the human bile to induce the L-form in vitro. The gallbladder specimens were collected from patients with biliary diseases to isolate the bacterial L-forms by the nonhigh osmotic isolation technique, and the H. pylori L-forms in the L-form isolates were identified by the gene assay for the H. pylori-specific genes 16S rRNA and UreA. RESULTS: The H. Pylori cannot be isolated from the bile-induced cultures, but the H. pylori L-form can be isolated from the H. pylori-negative bile-induced cultures. The L-form isolates of bile-induced cultures showed a positive reaction of the H. pylori-specific genes by PCR, and the coincidence ratio of the nucleotide sequences between the L-forms and the H. pylori is 99%. The isolation rate of bacteria L-form is 93.2% in the gallbladder specimens with bacteria-negative isolation culture by the nonhigh osmotic isolation technique, and the positive rate of the H. pylori-specific genes in the L-form isolates is 7.1% in the bacterial L-form-positive isolation cultures by the PCR. CONCLUSIONS: H. pylori can be rapidly induced into the L-form in the human bile; the L-form, as the latent bacteria, can live in the host gallbladder for a long times, and they made the host became a latent carrier of the H. pylori L-form. The H. pylori L-form can be isolated by the nonhigh osmotic isolation technique, and the variant can be identified by the gene assay for the H. pylori-specific genes 16S rRNA and reA.


Asunto(s)
Bilis/microbiología , Enfermedades de las Vías Biliares/microbiología , Vesícula Biliar/microbiología , Infecciones por Helicobacter/microbiología , Helicobacter pylori/aislamiento & purificación , Formas L/aislamiento & purificación , Portador Sano/microbiología , Helicobacter pylori/clasificación , Helicobacter pylori/genética , Humanos , Formas L/clasificación , Formas L/genética , Reacción en Cadena de la Polimerasa , Prohibitinas , ARN Ribosómico 16S/genética , Ureasa/genética
19.
Rev Chilena Infectol ; 32(4): 430-4, 2015 Aug.
Artículo en Español | MEDLINE | ID: mdl-26436787

RESUMEN

BACKGROUND: Bacteremia due to Streptococcus bovis (now S. gallolyticus) has been traditionally associated to colon or hepatobiliar disease and endocarditis but there is no information on this matter in Chile. AIMS: To describe clinical features of adult patients suffering bacteremia by S. bovis/S. gallolyticus, identify the source of the bacteremia and the frequency of endocarditis. METHODS: Retrospective-descriptive study using laboratory records. RESULTS: Between January 2003 and August 2014, 23 S. bovis/S. gallolyticus bacteremic events were identified among 22 patients. Mean age was 72.7 years (range 46-96). Co-morbidities were frequent (9.1 to 47.6%). The primary source of bacteremia was intestinal in 52.2%; hepatobiliar in 17.4% and in 34.8% it was not elucidated. Six patients had infective endocarditis (26.1%) and one patient had espondylodiscitis (4.3%). S. bovis represented 39.1% of isolates (all until 2008), S. gallolyticus subsp pasteurianus 39.1% and, S. gallolyticus subsp infantarius and S. gallolyticus subsp gallolyticus 8.7% each one, respectively. Association studies between the bacteremic source or endocarditis with specific S. gallolyticus subspecies were limited by the small number of isolates. Seven patients (30.4%) underwent surgical interventions. In-hospital mortality reached 21.7% (n=5). CONCLUSIONS: Although infrequent, bacteremic events by S. gallolyticus/S. bovis have increased in-hospital mortality, require surgical intervention and affect older patients with co-morbidities. Near two-thirds suffer from colonic or hepatobiliary disease that act as the primary source of bacteremia. In addition, near one fourth is affected by infective endocarditis. Detection of S. gallolyticus/S. bovis in blood cultures prompts a thorough clinical evaluation in order to clarify the source of the bloodstream infection and the presence of complications.


Asunto(s)
Bacteriemia/microbiología , Colangitis/microbiología , Enfermedades del Colon/microbiología , Endocarditis/microbiología , Absceso Hepático/microbiología , Infecciones Estreptocócicas/microbiología , Streptococcus bovis/clasificación , Anciano , Anciano de 80 o más Años , Enfermedades de las Vías Biliares/microbiología , Discitis/microbiología , Femenino , Mortalidad Hospitalaria , Humanos , Hepatopatías/microbiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Infecciones Estreptocócicas/mortalidad , Streptococcus bovis/patogenicidad
20.
BMC Gastroenterol ; 14: 104, 2014 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-24902609

RESUMEN

BACKGROUND: The aim of this study was to evaluate the association between obesity and infected bile or bacteremia in patients with acute calculous cholecystitis. METHODS: Authors analyzed the medical records of 139 patients who had undergone cholecystectomy for the treatment of acute calculous cholecystitis from January 2007 to June 2013 in a single teaching hospital. Association of body mass index (BMI) with bactibilia and bacteremia was assessed using univariate and multivariate analysis. Clinical findings and biliary infection related data were recorded for the following variables: gender, age, alcohol and smoking history, the results of blood and bile cultures, cholesterolosis, diabetes, hypertension, and duration of the hospital stay. RESULTS: The microbial culture rate of bactibilia and bacteremia were 50.4% and 21.6%, respectively. In the univariate analysis, bacteremia was associated with bactibilia (OR: 4.33, p = 0.002). In the multivariate analysis for the risk factors of bactibilia, BMI and bacteremia were related with bactibilia (OR: 0.59, 95% CI: 0.42-0.84, p = 0.003) (OR: 3.32, 95% CI: 1.22-9, p = 0.02). In the multivariate analysis for the risk factors of bacteremia, BMI, bactibilia and age were related with bacteremia (OR: 0.76, 95% CI: 0.59-0.99, p = 0.04) (OR: 3.46, 95% CI: 1.27-9.45, p = 0.02) (OR: 1.05, 95% CI: 1.01-1.09, p = 0.02). CONCLUSION: In this retrospective study, BMI was inversely correlated with bacteremia or bactibilia, which means obese or overweight patients are less likely to be associated with bacteremia or bactibilia in patients with acute calculous cholecystitis.


Asunto(s)
Bacteriemia/epidemiología , Bilis/microbiología , Colecistitis Aguda/epidemiología , Cálculos Biliares/epidemiología , Obesidad/epidemiología , Factores de Edad , Anciano , Anciano de 80 o más Años , Bacteriemia/microbiología , Enfermedades de las Vías Biliares/epidemiología , Enfermedades de las Vías Biliares/microbiología , Índice de Masa Corporal , Colecistectomía , Colecistitis Aguda/microbiología , Colecistitis Aguda/cirugía , Estudios de Cohortes , Comorbilidad , Femenino , Cálculos Biliares/microbiología , Cálculos Biliares/cirugía , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Retrospectivos , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda